Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial

Clinical trial NCT03531931 · UNKNOWN

Trial details

NCT number

NCT03531931

Sponsor

The First Affiliated Hospital of Xiamen University

Status

UNKNOWN

Study type

OBSERVATIONAL

Start date

2018-05-01

Primary completion

2023-05-01

Enrollment

20

View on ClinicalTrials.gov